A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis
Authors
Keywords
-
Journal
Gastroenterology Research and Practice
Volume 2016, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2016-01-21
DOI
10.1155/2016/3162595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term Comparative Efficacy of Cyclosporine- or Infliximab-based Strategies for the Management of Steroid-refractory Ulcerative Colitis Attacks
- (2014) Juan E. Naves et al. INFLAMMATORY BOWEL DISEASES
- Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis
- (2014) Alessandro Armuzzi et al. INFLAMMATORY BOWEL DISEASES
- Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab
- (2013) A. Croft et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Calcineurin Inhibitor Nephrotoxicity: A Review and Perspective of the Evidence
- (2013) Naim Issa et al. AMERICAN JOURNAL OF NEPHROLOGY
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients
- (2012) K. J. Schmidt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
- (2012) Parakkal Deepak et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mucosal healing in inflammatory bowel diseases: a systematic review
- (2012) Markus F Neurath et al. GUT
- Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis
- (2012) Kah Hoong Chang et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial
- (2012) David Laharie et al. LANCET
- Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2011) Khurram J Khan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
- (2011) W. Reinisch et al. GUT
- Tacrolimus Therapy as an Alternative to Thiopurines for Maintaining Remission in Patients With Refractory Ulcerative Colitis
- (2011) Shuji Yamamoto et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease
- (2010) Makoto Naganuma et al. JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
- (2009) J. P. GISBERT et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis
- (2008) S. YAMAMOTO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Comparative effectiveness of azathioprine in Crohn’s disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients
- (2008) J. P. GISBERT et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohnʼs disease: A single-center experience
- (2007) Aaron Benson et al. INFLAMMATORY BOWEL DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search